Last 12 months
Inside the activity.
1 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 15, 2016 Filed Nov 17, 2016 16:54 UTC |
JANDERNOA MICHAEL JDirector
|
GiftOrdinary Shares | 40,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001585364-16-000432 · wf-form4_147941963782035.xml · nonDerivative · entry 6 JANDERNOA MICHAEL J · CIK 0001024511 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · S. Jandernoa Trust. Disclosed balance after: 142,403 F3 · ownership.nature: Susan M. Jandernoa Trust of which Mrs. Jandernoa is the Trustee. Read SEC document |
| November 15, 2016 Filed Nov 17, 2016 16:54 UTC |
JANDERNOA MICHAEL JDirector
|
GiftOrdinary Shares | 40,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001585364-16-000432 · wf-form4_147941963782035.xml · nonDerivative · entry 5 JANDERNOA MICHAEL J · CIK 0001024511 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 387,654 F2 · ownership.nature: Michael J. Jandernoa Trust of which Mr. Jandernoa is the Trustee. Read SEC document |
| November 15, 2016 Filed Nov 17, 2016 16:54 UTC |
JANDERNOA MICHAEL JDirector
|
OtherOrdinary Shares | 248,964 | $0.00 | $0.00 |
DisclosureSEC source: 0001585364-16-000432 · wf-form4_147941963782035.xml · nonDerivative · entry 4 JANDERNOA MICHAEL J · CIK 0001024511 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 427,654 F1 · kind: Acquisition of shares as repayment of loan granted. F2 · ownership.nature: Michael J. Jandernoa Trust of which Mr. Jandernoa is the Trustee. Read SEC document |
| October 24, 2016 Filed Oct 26, 2016 18:44 UTC |
Brown Judy LEVP, Business Ops & CFO
|
SaleOrdinary Shares | 2,092 | $90.42 | $189,158.64 |
DisclosureSEC source: 0001585364-16-000421 · wf-form4_147750744224474.xml · nonDerivative · entry 1 Brown Judy L · CIK 0001355818 · EVP, Business Ops & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,104 F1 · kind: This transaction was effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on 6/17/2016. This 10b5-1 sales plan will expire on the close of business 6/17/2017. Read SEC document |
| September 26, 2016 Filed Sep 28, 2016 17:47 UTC |
Brown Judy LEVP, Business Ops & CFO
|
SaleOrdinary Shares | 2,096 | $96.76 | $202,808.96 |
DisclosureSEC source: 0001585364-16-000416 · wf-form4_147508484676884.xml · nonDerivative · entry 1 Brown Judy L · CIK 0001355818 · EVP, Business Ops & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,196 F1 · kind: This transaction was effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on 6/17/2016. This 10b5-1 sales plan will expire on the close of business 6/17/2017. Read SEC document |
| September 26, 2016 Filed Sep 28, 2016 13:47 UTC |
Farrington ThomasEVP and CIO
|
SaleOrdinary Shares | 1,110 | $96.76 | $107,403.60 |
DisclosureSEC source: 0001585364-16-000415 · wf-form4_147508482436180.xml · nonDerivative · entry 1 Farrington Thomas · CIK 0001398276 · EVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,970 F1 · kind: This transaction was effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on 11/9/2015 and amended 8/25/2016. This 10b5-1 sales plan will expire on the close of business 12/31/2016. Read SEC document |
| September 09, 2016 Filed Sep 13, 2016 15:01 UTC |
KUNKLE GARY K JRDirector
|
Exercise / conversionDirector Stock Option Right to Buy · Derivative | 5,814 | $0.00 Strike: $16.77 | $0.00 |
DisclosureSEC source: 0001585364-16-000412 · wf-form4_147379326625515.xml · derivative · entry 6 KUNKLE GARY K JR · CIK 0001201820 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 5,814 shares Expires 2016-11-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This option to purchase 5,814 New Perrigo ordinary shares for $16.77 per share, which was fully vested at the effective time of the Merger, was received in the Merger and represents the conversion of 5,814 Perrigo common stock shares for $16.77 per share. This New Perrigo stock option has the same terms and conditions as the original Perrigo stock option. Read SEC document |
| September 09, 2016 Filed Sep 13, 2016 15:01 UTC |
KUNKLE GARY K JRDirector
|
SaleOrdinary Shares | 100 | $89.96 | $8,996.00 |
DisclosureSEC source: 0001585364-16-000412 · wf-form4_147379326625515.xml · nonDerivative · entry 5 KUNKLE GARY K JR · CIK 0001201820 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,687 Read SEC document |
| September 09, 2016 Filed Sep 13, 2016 15:01 UTC |
KUNKLE GARY K JRDirector
|
SaleOrdinary Shares | 2,000 | $89.96 | $179,910.00 |
DisclosureSEC source: 0001585364-16-000412 · wf-form4_147379326625515.xml · nonDerivative · entry 4 KUNKLE GARY K JR · CIK 0001201820 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,787 Read SEC document |
| September 09, 2016 Filed Sep 13, 2016 15:01 UTC |
KUNKLE GARY K JRDirector
|
SaleOrdinary Shares | 2,414 | $89.95 | $217,139.30 |
DisclosureSEC source: 0001585364-16-000412 · wf-form4_147379326625515.xml · nonDerivative · entry 3 KUNKLE GARY K JR · CIK 0001201820 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,787 Read SEC document |
| September 09, 2016 Filed Sep 13, 2016 15:01 UTC |
KUNKLE GARY K JRDirector
|
SaleOrdinary Shares | 1,300 | $89.95 | $116,928.50 |
DisclosureSEC source: 0001585364-16-000412 · wf-form4_147379326625515.xml · nonDerivative · entry 2 KUNKLE GARY K JR · CIK 0001201820 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,201 Read SEC document |
| September 09, 2016 Filed Sep 13, 2016 15:01 UTC |
KUNKLE GARY K JRDirector
|
Exercise / conversionOrdinary Shares | 5,814 | $16.77 | $97,500.78 |
DisclosureSEC source: 0001585364-16-000412 · wf-form4_147379326625515.xml · nonDerivative · entry 1 KUNKLE GARY K JR · CIK 0001201820 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,501 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 08, 2016 Filed Sep 9, 2016 16:33 UTC |
MORRIS HERMAN JRDirector
|
Exercise / conversionDirector Stock Option Right to Buy · Derivative | 5,814 | $0.00 Strike: $16.77 | $0.00 |
DisclosureSEC source: 0001585364-16-000410 · wf-form4_147345319622188.xml · derivative · entry 4 MORRIS HERMAN JR · CIK 0001223614 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 5,814 shares Expires 2017-11-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option to purchase 5,814 New Perrigo ordinary shares for $16.77 per share, which was fully vested at the effective time of the Merger, was received in the Merger and represents the conversion of 5,814 Perrigo common stock shares for $16.77 per share. This New Perrigo stock option has the same terms and conditions as the original Perrigo stock option. Read SEC document |
| September 08, 2016 Filed Sep 9, 2016 16:33 UTC |
MORRIS HERMAN JRDirector
|
SaleOrdinary Shares | 1,073 | $90.96 | $97,594.72 |
DisclosureSEC source: 0001585364-16-000410 · wf-form4_147345319622188.xml · nonDerivative · entry 2 MORRIS HERMAN JR · CIK 0001223614 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,352 Read SEC document |
| September 08, 2016 Filed Sep 9, 2016 16:33 UTC |
MORRIS HERMAN JRDirector
|
Exercise / conversionOrdinary Shares | 5,814 | $16.77 | $97,500.78 |
DisclosureSEC source: 0001585364-16-000410 · wf-form4_147345319622188.xml · nonDerivative · entry 1 MORRIS HERMAN JR · CIK 0001223614 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,425 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 19, 2016 Filed May 19, 2017 18:04 UTC Amendment |
BRLAS LAURIEDirector
|
GrantRestricted Stock Units · Derivative | 3,263 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001585364-17-000061 · wf-form4a_149521704176214.xml · derivative · entry 2 BRLAS LAURIE · CIK 0001235612 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,263 Underlying: Ordinary Shares · 3,263 shares Expires 2017-05-19 F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. F1 · price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. F2 · derivative.exercise_date: The Reporting Person has voluntarily agreed to postpone the vesting of this award until such time as the Issuer is current in its filings under the Securities Exchange Act of 1934. F2 · derivative.expiration_date: The Reporting Person has voluntarily agreed to postpone the vesting of this award until such time as the Issuer is current in its filings under the Securities Exchange Act of 1934. Read SEC document |
| May 19, 2016 Filed May 19, 2017 14:00 UTC Amendment |
COHEN GARY MDirector
|
GrantRestricted Stock Units · Derivative | 3,263 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001585364-17-000060 · wf-form4a_149521682679953.xml · derivative · entry 2 COHEN GARY M · CIK 0001223637 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,263 Underlying: Ordinary Shares · 3,263 shares Expires 2017-05-19 F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. F1 · price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. F2 · derivative.exercise_date: The Reporting Person has voluntarily agreed to postpone the vesting of this award until such time as the Issuer is current in its filings under the Securities Exchange Act of 1934. F2 · derivative.expiration_date: The Reporting Person has voluntarily agreed to postpone the vesting of this award until such time as the Issuer is current in its filings under the Securities Exchange Act of 1934. Read SEC document |
| May 19, 2016 Filed May 19, 2017 17:27 UTC Amendment |
O'Connor DonalDirector
|
GrantRestricted Stock Units · Derivative | 3,263 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001585364-17-000058 · wf-form4a_149521481631250.xml · derivative · entry 3 O'Connor Donal · CIK 0001625377 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,263 Underlying: Ordinary Shares · 3,263 shares Expires 2017-05-19 F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. F1 · price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. F2 · derivative.exercise_date: The Reporting Person has voluntarily agreed to postpone the vesting of this award until such time as the Issuer is current in its filings under the Securities Exchange Act of 1934. F2 · derivative.expiration_date: The Reporting Person has voluntarily agreed to postpone the vesting of this award until such time as the Issuer is current in its filings under the Securities Exchange Act of 1934. Read SEC document |
| May 14, 2015 Filed May 19, 2017 13:47 UTC Amendment |
Needham JeffreyEVP, GM Consumer Healthcare
|
GrantRestricted Stock Units · Derivative | 515 | $0.00 | $0.00 |
DisclosureSEC source: 0001585364-17-000059 · wf-form4a_149521604223179.xml · derivative · entry 2 Needham Jeffrey · CIK 0001398335 · EVP, GM Consumer Healthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 515 Underlying: Ordinary Shares · 515 shares Expires 2017-05-14 F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of Perrigo Company plc ordinary shares. F2 · kind: Restricted Stock Units awarded for capacity as EVP, pursuant to the 2013 Long-term Incentive Plan. F1 · price: Each Restricted Stock Unit represents a contingent right to receive one share of Perrigo Company plc ordinary shares. F3 · derivative.exercise_date: The Reporting Person has voluntarily agreed to postpone the vesting of this award until such time as the Issuer is current in its filings under the Securities Exchange Act of 1934. F3 · derivative.expiration_date: The Reporting Person has voluntarily agreed to postpone the vesting of this award until such time as the Issuer is current in its filings under the Securities Exchange Act of 1934. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.